NCT05620017 2026-02-09
Evaluate the Safety, Tolerability and Pharmacokinetic Characteristics of BAT8008 for Injection
Bio-Thera Solutions
Phase 1 Recruiting
Bio-Thera Solutions
NextCure, Inc.
Changchun GeneScience Pharmaceutical Co., Ltd.
Changchun GeneScience Pharmaceutical Co., Ltd.